Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.58 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | NQO1 | P15559 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | PLK1 | P53350 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL458087 | 0.92 | ACACB (0.59) | — | |
| SCHEMBL2628190 | 0.86 | SMN1; SMN2 (0.59) | CYP4F2CYP4A11ALDH1A1NPC1RAB9A | |
| SCHEMBL3333378 | 0.86 | KDM4E (0.69) | CYP4F2CYP4A11ALDH1A1NPC1RAB9A | |
| SCHEMBL25255900 | 0.85 | CYP4F2 (0.62) | CYP4F2CYP4A11ALDH1A1NPC1RAB9A | |
| SCHEMBL4275929 | 0.85 | SMN1; SMN2 (0.58) | CYP4F2CYP4A11ALDH1A1NPC1RAB9A | |
| SCHEMBL12688088 | 0.85 | NPC1 (0.70) | CYP4F2CYP4A11ALDH1A1NPC1RAB9A | |
| SCHEMBL181473 | 0.85 | HPGD (0.61) | ALDH1A1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL5551453 | 0.85 | GAA (0.59) | CYP4F2CYP4A11ALDH1A1NPC1RAB9A | |
| SCHEMBL9584950 | 0.85 | AKR1C3 (0.54) | CYP4F2CYP4A11ALDH1A1NPC1RAB9A | |
| SCHEMBL4113212 | 0.84 | CYP4F2 (0.76) | CYP4F2CYP4A11ALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109096420-B | Catalyst for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2021-05-11 | — | — | CN | claimed |
| US-RE49934-E1 | Inhibitors of cellular metabolic processes | SERVIER PHARMACEUTICALS LLC (US) | 2024-04-23 | — | — | US | disclosed |
| CN-116554050-A | Amide phenol derivative and application thereof | 四川大学 | 2023-08-08 | — | — | CN | disclosed |
| CN-109890822-B | Inhibitors of cellular metabolic processes | 安吉奥斯医药品有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-11325914-B1 | Inhibitors of cellular metabolic processes | SERVIER PHARMACEUTICALS LLC (US) | 2022-05-10 | — | — | US | disclosed |
| CN-109096420-B | Catalyst for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2021-05-11 | — | — | CN | disclosed |
| US-10800782-B2 | Inhibitors of cellular metabolic processes | Agios Pharmaceutical, Inc. (US) | 2020-10-13 | — | — | US | disclosed |
| EP-3397616-B1 | LSD1 INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2020-06-10 | — | — | EP | disclosed |
| US-20190233424-A1 | INHIBITORS OF CELLULAR METABOLIC PROCESSES | SERVIER PHARMACEUTICALS LLC | 2019-08-01 | — | — | US | disclosed |
| EP-3507290-A1 | INHIBITORS OF CELLULAR METABOLIC PROCESSES | Agios Pharmaceuticals, Inc. (US) | 2019-07-10 | — | — | EP | disclosed |
| US-7384955-B2 | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | ASTRAZENECA AB (SE) | 2008-06-10 | — | — | US | disclosed |
| US-7384955-B2 | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | ASTRAZENECA AB (SE) | 2008-06-10 | — | — | US | disclosed |
| US-20070027179-A1 | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | ASTRAZENECA AB (SE) | 2007-02-01 | — | — | US | disclosed |
| US-20070027179-A1 | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | ASTRAZENECA AB (SE) | 2007-02-01 | — | — | US | disclosed |
| US-20070027179-A1 | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | ASTRAZENECA AB (SE) | 2007-02-01 | — | — | US | disclosed |
| EP-1615922-A1 | AZAINDOLE DERIVATIVES, PREPARATIONS THEREOF, USES THEREOF AND COMPOSITIONS CONTAINING THEM | AstraZeneca AB (SE) | 2006-01-18 | — | — | EP | disclosed |
| CN-1183107-C | Alkynyl containing hydroxamic acid compounds as TACE inhibitors | ���Ͽع�����˾ | 2005-01-05 | — | — | CN | disclosed |
| WO-2004087704-A1 | AZAINDOLE DERIVATIVES, PREPARATIONS THEREOF, USES THEREOF AND COMPOSITIONS CONTAINING THEM | ASTRAZENECA AB (SE) | 2004-10-14 | — | — | WO | disclosed |
| CN-1337945-A | Alkynyl containing hydroxamic acid compounds as TACE inhibitors | AMERICAN CYANAMID CO (US) | 2002-02-27 | — | — | CN | disclosed |
| US-4560447-A | Electrolytic process for preparation of α-alkylated acetic acid derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1985-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190233424-A1 | INHIBITORS OF CELLULAR METABOLIC PROCESSES | MNAT1, MAT2A, PCK2 | CYP4F2 867/4885CYP4A11 2866/4885ALDH1A1 352/4885 |
| US-10800782-B2 | Inhibitors of cellular metabolic processes | MNAT1, MAT2A, PCK2 | CYP4F2 867/4885CYP4A11 2866/4885ALDH1A1 352/4885 |
| US-20070027179-A1 | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | ADRA2A, ADRA1A, ADORA2A | CYP4F2 1055/4885CYP4A11 660/4885ALDH1A1 404/4885 |
| US-11325914-B1 | Inhibitors of cellular metabolic processes | MNAT1, MAT2A, PCK2 | CYP4F2 867/4885CYP4A11 2866/4885ALDH1A1 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.